OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of 1,2,4-triazine dithiocarbamate derivatives as NEDDylation agonists to inhibit gastric cancers
Jian Song, Yuan Liu, Xin-Ying Yuan, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113801-113801
Closed Access | Times Cited: 20

Showing 20 citing articles:

Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions
Dong‐Jun Fu, Ting Wang
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 24

Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities
Yaxin Sun, Jian Song, Lijun Kong, et al.
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 114069-114069
Closed Access | Times Cited: 40

Targeting cullin neddylation for cancer and fibrotic diseases
Zhangxu He, Wei-guang Yang, Dan Zengyangzong, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 5017-5056
Open Access | Times Cited: 13

A multi-target directed ligands strategy for the treatment of Alzheimer's disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 activator
Jie Guo, Maojun Cheng, Peng Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114630-114630
Closed Access | Times Cited: 21

Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics
Na Li, Yunhe Liu, Ji Yuan Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116694-116694
Closed Access | Times Cited: 4

NAE1 protein: a prognostic, immunomodulatory, and therapeutic biomarker associated with neddylation in hepatocellular carcinoma
Yong Pan, Jinyao Dai, Yi Liu, et al.
International Journal of Biological Macromolecules (2025) Vol. 310, pp. 143539-143539
Closed Access

Design, synthesis and biological evaluation of rhein-piperazine-dithiocarbamate hybrids as potential anticancer agents
Meng‐Xue Wei, Yixuan Zhou, Mengxia Lin, et al.
European Journal of Medicinal Chemistry (2022) Vol. 241, pp. 114651-114651
Closed Access | Times Cited: 13

Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms
Lydia W. Njenga, Simon N. Mbugua, Ruth A. Odhiambo, et al.
Dalton Transactions (2023) Vol. 52, Iss. 18, pp. 5823-5847
Closed Access | Times Cited: 7

Recent updates on 1,2,3‐, 1,2,4‐, and 1,3,5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action
Gaoli Dong, Yingchun Jiang, Feng Zhang, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 3
Closed Access | Times Cited: 12

NAE modulators: A potential therapy for gastric carcinoma
Qi Liang, Maoyu Liu, Jian Li, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114156-114156
Closed Access | Times Cited: 9

Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities
Liyao Tang, Yan Zhang, Jinrun Xu, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1414-1414
Open Access | Times Cited: 4

Facile synthesis of tetrahydroquinoline containing dithiocarbamate derivatives via one-pot sequential multicomponent reaction
Siddhartha Kumar Senapati, Anit Pal, Animesh Das
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 20, pp. 4041-4046
Closed Access | Times Cited: 1

Design, concise synthesis and evaluation of novel amide-based combretastatin A-4 analogues as potent tubulin inhibitors
Yu-Feng Ma, Ting Wang, Cheng Li, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 108, pp. 129816-129816
Closed Access | Times Cited: 1

Discovery of novel 1,2,4-triazine-chalcone hybrids as anti-gastric cancer agents via an axis of ROS-ERK-DR5 in vitro and in vivo
Liu Chong, Jian Song, Xinxin Cui, et al.
Arabian Journal of Chemistry (2021) Vol. 15, Iss. 3, pp. 103644-103644
Open Access | Times Cited: 10

Role of non-canonical post-translational modifications in gastrointestinal tumors
Yi‐Hong Liu, Jingwei Liu, Na Peng, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2

In vitrocytotoxicity and antibacterial activity of [Pd(AMTTO)(PPh3)2]: a novel promising palladium(ii) complex
Atousa Goudarzi, Mitra Ghassemzadeh, Maryam Saeidifar, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 6, pp. 3026-3034
Closed Access | Times Cited: 4

Discovery of dual tubulin-NEDDylation inhibitors with antiproliferative activity
Dong‐Jun Fu, Ting Wang
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 166-175
Open Access | Times Cited: 3

Synthesis and antitumor evaluation of glycyrrhetinic acid‐dithiocarbamate hybrids
Jiahong Su, Xingyue Wang, Sha Li, et al.
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access

Triazines, tetrazines, and fused ring polyaza systems
R. A. Aitken, Fiona M. Fotherby
Progress in heterocyclic chemistry (2023), pp. 469-485
Closed Access | Times Cited: 1

Design, Synthesis and Anti‐Tumor Activity Evaluation of Novel 3,4‐(Methylenedioxy)cinnamic Acid Amide‐Dithiocarbamate Derivatives
Jie Guo, Maojun Cheng, Peng Liu, et al.
Chemistry & Biodiversity (2022) Vol. 19, Iss. 8
Closed Access | Times Cited: 1

Page 1

Scroll to top